Philip releases Chinese version of 2023 Future Health Index Report

Philip releases Chinese version of 2023 Future Health Index Report

Philip (China) released the 2023 Chinese version of the "Future Health Index Report: Integration of Data and Intelligence, Health Without Boundaries" during the CIIE. As one of the largest surveys of its kind in the world, the report surveyed nearly 3,000 managers and younger generations of medical professionals in the medical and health industry in 14 countries and regions around the world, focusing on the issues of digital intelligence empowerment and interconnection. The development status and future trends of innovative medical service models show how industry managers and practitioners can leverage digital technology to jointly promote industry development and better meet the unmet needs of patients. This is also the eighth consecutive year that Philip has conducted a global "Future Health Index" survey since its focus on the transformation of "health technology". It is committed to relying on its keen insights into the industry to provide valuable reference and guidance for the development of the medical and health industry.

In recent years, affected by multiple factors, global public health has faced multiple challenges. Among them, the shortage of medical staff and the pressure on the economic operation of the medical system have become key constraints to the development of the industry. In China, medical and health industry managers are actively taking countermeasures. They expect that booming digital technology can help them alleviate the pressure caused by insufficient manpower and financial constraints, and help them build a more efficient and flexible medical service system. Specifically, managers in China’s medical and health industry hope to use digital means such as workflow technology (48%), key decision support technology (41%), and communication technology (41%) to solve the problem of shortage of medical staff; while also leveraging automation and other technologies to streamline workflow (41%) and patient pathways (35%) to achieve cost reduction and efficiency improvement.

In addition, China's medical and health industry is also at the world's leading level in the application and promotion of artificial intelligence technology. 54% of Chinese healthcare industry managers said in the survey that they are investing heavily in the field of artificial intelligence, especially artificial intelligence technology used for prediction of care outcomes (33%) and integrated diagnosis (32%). For young medical professionals, the degree of application of artificial intelligence has also become an important consideration when choosing a career (39%).

As a pioneer in the field of medical artificial intelligence, Philip has rich innovation accumulation and practical experience in this field. This year, the deep learning algorithm jointly developed by Philip and domestic tertiary hospitals won the first prize at the CAS23 Intracranial Artery Segmentation Competition, an AI+ medical imaging heavyweight event organized by the International Society of Magnetic Resonance Vascular Imaging and the Medical Image Computing and Intervention Association (MICCAI). Winning the first place provides a powerful reference for the development of automatic cerebral artery segmentation algorithms, and further demonstrates Philip' strong innovative research and development capabilities.

The report also emphasizes that in addition to improving medical service capabilities, medical and health industry managers are also vigorously promoting the sustainable development of the industry and regard it as a key task for hospitals and medical institutions. They plan to fully promote sustainable development initiatives and lead green and low-carbon medical care by setting clear sustainable development goals and measurement mechanisms (43%) and expanding tripartite cooperation (34%). For many young medical professionals, “sustainability” is also a key consideration when choosing an organization for employment (46%).